This document summarizes research on uncontrolled asthma among Medicaid-enrolled children. It explores the challenges of asthma, why this demographic is uniquely affected, and the potential for improved disease management. Key points include: asthma affects 20 million Americans and costs $59 billion annually; Medicaid children have poorer control and higher costs despite lower direct healthcare costs; socioeconomic factors like poverty, housing, and access to care do not fully explain disparities; and research shows racial disparities in prescription of preventative medications like inhaled corticosteroids that lead to unnecessary hospitalizations and exacerbations.